GABRG2 rs5400: Understanding This Genetic Variant
The rs5400 variant is a genetic marker located within the GABRG2 gene, which provides instructions for building a critical component of the brain's inhibitory signaling system. Research has investigated this variant for its potential association with variations in GABA receptor subunit expression and susceptibility to certain forms of epilepsy.
What each genotype means
Typical GABRG2 expression
This genotype represents the most common form of the GABRG2 gene in the general population. Research indicates that GABRG2 is critical for GABA receptor function, and this genotype is generally considered the baseline against which potential epilepsy-associated variants are measured.
This is the most frequent genotype observed across all major global populations.
Common variant carrier
Carrying one copy of this variant is common and is not inherently diagnostic of a medical condition. While GABRG2 variants are studied for their role in epilepsy susceptibility, the presence of this specific genotype alone does not confirm an increased risk for seizures. Please consult with a healthcare provider or genetic counselor to discuss any personal or family history of neurological conditions.
This genotype is found at varying frequencies across global populations, appearing in a significant portion of the general public.
Variant carrier
This genotype indicates the presence of two copies of the variant allele. While research links certain GABRG2 mutations to a spectrum of epilepsy syndromes and febrile seizures, the clinical significance of this specific variant depends on its functional impact on the GABA receptor. You should discuss this result with a clinician to determine if it is relevant to your health profile.
This genotype is less common than the CC or CT configurations but is present in the general population.
What is the rs5400 Variant?
The rs5400 variant is a single nucleotide polymorphism (SNP) found within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is situated in a region of the genome that influences how the body produces the gamma-2 subunit of the GABA-A receptor. Because this receptor is essential for regulating electrical activity in the brain, researchers often study variants in this gene to understand how subtle changes in DNA might influence neurological health. While rs5400 is a common variant, it is distinct from rare, pathogenic mutations in the same gene that are known to cause severe, early-onset developmental and epileptic encephalopathies.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are the primary inhibitory neurotransmitter receptors in the mammalian brain. They function like a 'brake' system, helping to calm neuronal activity and maintain a balance between excitation and inhibition. When these receptors function correctly, they prevent the brain from becoming overstimulated. If the GABRG2 gene produces a subunit that is structurally altered or expressed at different levels, it can potentially disrupt the formation or efficiency of these receptors. This disruption is why GABRG2 is a major focus in epilepsy research; the gene's integrity is vital for preventing the uncontrolled electrical discharges that characterize seizure disorders.
Research and Evidence Strength
Scientific evidence linking rs5400 to health outcomes is considered moderate. While some studies have explored its role in the context of epilepsy risk, the findings are often complex and not always consistent across different populations. It is important to distinguish between common variants like rs5400 and rare, highly penetrant mutations in GABRG2 that have a direct, causative link to severe epilepsy syndromes. Current research suggests that rs5400 may contribute to a broader spectrum of susceptibility rather than acting as a single, definitive cause of disease. Because epilepsy is a multifactorial condition influenced by many genes and environmental factors, the presence of this variant alone is not a diagnostic indicator of any medical condition.
Population Frequency
The rs5400 variant is classified as a common polymorphism, meaning it is found frequently across diverse human populations. Because it is common, it is considered a normal part of human genetic variation. Its frequency does not typically vary drastically between major ancestral groups, though minor differences in allele distribution are often observed in large-scale genomic databases. This widespread presence reinforces the idea that the variant is likely a neutral or low-impact contributor to human biology for the vast majority of people, rather than a rare mutation associated with specific clinical disorders.
What This Information Means for You
Learning about a variant like rs5400 provides insight into your genetic makeup, but it does not constitute a medical diagnosis. Genetic associations are statistical observations made across large groups of people and cannot predict an individual's health outcome with certainty. If you have concerns about your neurological health, family history of seizures, or how your genetics might influence your response to medications, it is essential to consult with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your personal medical history. Never make changes to prescribed medications or treatment plans based on genetic reports without first discussing them with your clinician or pharmacist.
How common is this variant?
The rs5400 variant is a common polymorphism found across global populations, with its various genotypes appearing frequently in healthy individuals.
Frequently asked questions
Does having the rs5400 variant mean I will develop epilepsy?
No. The rs5400 variant is a common genetic marker and is not a direct cause of epilepsy. Most people who carry this variant do not have any seizure disorders.
Is rs5400 the same as the GABRG2 mutations that cause severe epilepsy?
No. Rare, pathogenic mutations in GABRG2 are distinct from common variants like rs5400. Pathogenic mutations are typically associated with specific, severe developmental and epileptic encephalopathies.
Should I be worried about my GABRG2 genotype?
There is no reason for concern. rs5400 is a common variation in the human genome. Genetic variants are only one small piece of the puzzle regarding overall health.
Can I use this information to change my medication?
Absolutely not. You should never change or stop any medication based on genetic information without consulting your doctor or pharmacist, as this could be dangerous.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5400?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.